| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 56, 715-719, Copyright © 1983 by Endocrine Society
ARTICLES |
DE Pittaway, RN Andersen, SA Coleman Jr, JR Givens and WL Wiser
Ovarian tissue and ovarian venous blood were obtained from women undergoing wedge resection, and ovarian tissue was obtained from normally menstruating women who had an oophorectomy for medical reasons. A morphological evaluation was made of the wedged tissue. 17 beta-Hydroxysteroid oxidoreductase levels were determined as the 17- ketoreductase (17-KR) and 17 beta-dehydrogenase activities in both normal and wedged tissue. Plasma androstenedione (A) and testosterone (T) levels were measured in the ovarian venous blood. Low, but measurable, 17 beta-hydroxysteroid oxidoreductase activity was found in the mitochondria, microsomes, and cytosol. With whole, cell-free homogenates, mean 17-KR activity was not significantly different in normal tissues and polycystic tissues; mean 17-KR activity of corpora lutea was significantly greater than that of the other tissues. Mean 17 beta-dehydrogenase activity was not significantly different from 17-KR activity in the tissues studied. Ovarian venous A levels were higher than the reported mean ovarian venous A levels of normal women with only one exception; approximately half of the ovarian venous T levels were higher than reported mean ovarian venous T levels of normal women. The morphology of the wedge sections did not correlate well with the biochemical data.
This article has been cited by other articles:
![]() |
V. L. Nelson, K.-n. Qin, R. L. Rosenfield, J. R. Wood, T. M. Penning, R. S. Legro, J. F. Strauss III, and J. M. McAllister The Biochemical Basis for Increased Testosterone Production in Theca Cells Propagated from Patients with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5925 - 5933. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-n. Qin and R. L. Rosenfield Expression of 17{beta}-Hydroxysteroid Dehydrogenase Type 5 in Human Ovary: A Pilot Study Reproductive Sciences, January 1, 2000; 7(1): 61 - 64. [Abstract] [PDF] |
||||
![]() |
I. Dufort, P. Rheault, X.-F. Huang, P. Soucy, and V. Luu-The Characteristics of a Highly Labile Human Type 5 17{beta}-Hydroxysteroid Dehydrogenase Endocrinology, February 1, 1999; 140(2): 568 - 574. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |